Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2012 | 07-2012 | 06-2012 | 04-2012 | 03-2012 | |
Sales | 39 | 7,472 | 49 | 7,361 | 72 |
Cost of Goods | 988 | 5,225 | 208 | 4,503 | 280 |
Gross Profit | -949 | 2,247 | -159 | 2,858 | -208 |
Operating Expenses | 5,004 | 2,633 | 3,682 | 2,641 | 3,819 |
Operating Income | -4,965 | -161 | -3,633 | 720 | -3,747 |
Interest Expense | 7 | 66 | 1 | 73 | 11 |
Other Income | -1,615 | 6 | 634 | 0 | 1,450 |
Pre-tax Income | -6,587 | -221 | -3,000 | 647 | -2,308 |
Income Tax | N/A | -83 | N/A | 234 | N/A |
Net Income Continuous | -6,587 | -138 | -3,000 | 413 | -2,308 |
Net Income | $-6,587 | $-138 | $-3,000 | $413 | $-2,308 |
EPS Basic Total Ops | -26.44 | -0.04 | -10.58 | 0.11 | -10.58 |
EPS Basic Continuous Ops | -25.42 | -0.04 | -11.67 | 0.11 | -8.99 |
EPS Diluted Total Ops | -26.44 | -0.04 | -10.58 | 0.10 | -10.58 |
EPS Diluted Continuous Ops | -25.42 | -0.04 | -11.67 | 0.10 | -8.99 |
EBITDA(a) | $-4,768 | $9 | $-3,483 | $880 | $-3,596 |